Review article · 2015 · Open access

Can We Use Social Media to Support Content Validity of Patient-Reported Outcome Instruments in Medical Product Development?

Margaret L. Rothman, Ari Gnanaskathy, Paul J Wicks, Elektra J. Papadopoulos

Value in Health, 18(1), 1–4 · Published 1 January 2015 · DOI 10.1016/j.jval.2014.10.001

Open full textCite this paper

In brief

“Can We Use Social Media to Support Content Validity of Patient-Reported Outcome Instruments in Medical Product Development?” is a 2015 review article by Margaret L. Rothman and 3 co-authors, published in Value in Health. OpenAlex counts 44 citations as of 22 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at Value in Health.

Citations
44
Most cited in
2018 (7)
Field-weighted impact
0.92
References
26
Authors
4

Abstract

We report a panel designed to open a dialog between pharmaceutical sponsors, regulatory reviewers, and other stakeholders regarding the use of social media to collect data to support the content validity of patient-reported outcome instruments in the context of medical product labeling. Multiple stakeholder perspectives were brought together to better understand the issues encountered in pursuing social media as a form of data collection to support content validity. Presenters represented a pharmaceutical sponsor of clinical trials, a regulatory reviewer from the Food and Drug Administration, and an online data platform provider. Each presenter shared its perspective on the advantages and disadvantages of using social media to collect this type of information. There was consensus that there is great potential for using social media for this purpose. There remain, however, unanswered questions that need to be addressed such as identifying which type of social media is most appropriate for data collection and ensuring that participants are representative of the target population while maintaining the advantages of anonymity provided by online platforms. The use of social media to collect evidence of content validity holds much promise. Clarification of issues that need to be addressed and accumulation of empirical evidence to address these questions are essential to moving forward.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Rothman, M. L., Gnanaskathy, A., Wicks, P. J., & Papadopoulos, E. J. (2015). Can We Use Social Media to Support Content Validity of Patient-Reported Outcome Instruments in Medical Product Development? Value in Health, 18(1), 1–4. https://doi.org/10.1016/j.jval.2014.10.001

MLA 9

Rothman, Margaret L., et al. “Can We Use Social Media to Support Content Validity of Patient-Reported Outcome Instruments in Medical Product Development?” Value in Health, vol. 18, no. 1, 2015, pp. 1–4. https://doi.org/10.1016/j.jval.2014.10.001.

Chicago

Rothman, Margaret L., Ari Gnanaskathy, Paul J Wicks, and Elektra J. Papadopoulos. 2015. “Can We Use Social Media to Support Content Validity of Patient-Reported Outcome Instruments in Medical Product Development?” Value in Health 18 (1): 1–4. https://doi.org/10.1016/j.jval.2014.10.001.

Harvard

Rothman, M. L. et al. (2015) ‘Can We Use Social Media to Support Content Validity of Patient-Reported Outcome Instruments in Medical Product Development?’, Value in Health, 18(1), pp. 1–4. doi:10.1016/j.jval.2014.10.001.

IEEE

M. L. Rothman, A. Gnanaskathy, P. J. Wicks, and E. J. Papadopoulos, “Can We Use Social Media to Support Content Validity of Patient-Reported Outcome Instruments in Medical Product Development?,” Value in Health, vol. 18, no. 1, pp. 1–4, 2015, doi: 10.1016/j.jval.2014.10.001.

BibTeX

@article{rothman2015social,
  title     = {{Can We Use Social Media to Support Content Validity of Patient-Reported Outcome Instruments in Medical Product Development?}},
  author    = {Rothman, Margaret L. and Gnanaskathy, Ari and Wicks, Paul J and Papadopoulos, Elektra J.},
  journal   = {Value in Health},
  year      = {2015},
  volume    = {18},
  number    = {1},
  pages     = {1--4},
  doi       = {10.1016/j.jval.2014.10.001},
  url       = {https://doi.org/10.1016/j.jval.2014.10.001}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201744
201877
201955
202022
202111
202255
202355
202433
202511
202611

Its field-weighted citation impact is 0.92: it has been cited 0.92 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Social Sciences › Social Sciences › Health › Social Media in Health Education

  • social media
  • content validity
  • patient-reported outcome measures
  • medical product development
  • pharmaceutical sponsors
  • regulatory review
  • stakeholder perspectives
  • online data collection

Work with this paper

Most-cited papers in Social Sciences

All highly cited Social Sciences papers

Questions about this paper

How do I cite this paper in APA style?

Rothman, M. L., Gnanaskathy, A., Wicks, P. J., & Papadopoulos, E. J. (2015). Can We Use Social Media to Support Content Validity of Patient-Reported Outcome Instruments in Medical Product Development? Value in Health, 18(1), 1–4. https://doi.org/10.1016/j.jval.2014.10.001

How many times has this paper been cited?

44 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Value in Health: sign in and open the full text from this page.

Who wrote this paper?

Margaret L. Rothman, Ari Gnanaskathy, Paul J Wicks, Elektra J. Papadopoulos.

What is the DOI of this paper?

10.1016/j.jval.2014.10.001, permanently at https://doi.org/10.1016/j.jval.2014.10.001. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.